Abstract
Interest in the gastrointestinal (GI) factors of autistic disorder (autism) has developed from descriptions of symptoms such as constipation and diarrhea in autistic children and advanced towards more detailed studies of GI histopathology and treatment modalities. This review attempts to critically and comprehensively analyze the literature as it applies to all aspects of GI factors in autism, including discussion of symptoms, pathology, nutrition, and treatment. While much literature is available on this topic, a dearth of rigorous study was found to validate GI factors specific to children with autism.
Similar content being viewed by others
References
Afzal N., Murch S., Thirrupathy K., Berger L., Fagbemi A., Heuschkel R. (2003). Constipation with acquired megarectum in children with autism Pediatrics 112: 939–942
Ahearn W. H., Castine T., Nault K., Green G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified Journal of Autism and Developmental Disorders 31: 505–511
Alberti A., Pirrone P., Elia M., Waring R. H., Romano C. (1999). Sulphation deficit in “low-functioning” autistic children: A pilot study Biological Psychiatry 46: 420–424
American Psychiatric Association, (1987). Diagnostic and statistical manual of mental disorders (3rd ed., revised). American Psychiatric Association
Banov C. H. (1979). Risks with controlling diet Journal of Autism and Developmental Disorders 9: 135–136
Black C., Kaye J. A., Jick H. (2002). Relation of childhood gastrointestinal disorders to autism: Nested case–control study using data from the UK General Practice Research Database British Medical Journal 325: 419–421
Carey T., Ratliff-Schaub K., Funk J., Weinle C., Myers M., Jenks J. (2002). Double-blind placebo-controlled trial of secretin: Effects on aberrant behavior in children with autism Journal of Autism and Developmental Disorders 32: 161–167
Chez M. G., Buchanan C. P., Bagan B. T. (2000). Secretin and autism: A two part clinical investigation Journal of Autism and Developmental Disorders 30: 87–94
Cohen D. J., Johnson W. T., Caparulo B. K. (1976). Pica and elevated blood lead level in autistic and atypical children American Journal of Diseases of Children 130: 47–48
Coniglio S. J., Lewis J. D., Lang C., Burns T. G. (2001). A randomized, double-blind, placebo controlled trial of single-dose intravenous secretin as a treatment for children with autism Journal of Pediatrics 138: 649–655
Corbett, B., Khan, K., Czapansky-Beilman, D., & Brady, N. (2001). A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Clinical Pediatrics, 325–331
Cornish E. (2002). Gluten and casein free diets in autism: A study of the effects on food choice and nutrition Journal of Human Nutrition and Dietetics 15: 261–269
D’Eufemia P., Celli M., Finocchiaro R., Pacifico L., Viozzi L., Zaccagnini M., Cardi E., Giardini O. (1996). Abnormal intestinal permeability in children with autism Acta Paediatrica 85: 1076–1079
Dalrymple N. J., Ruble L. A. (1992). Toilet training and behaviors of people with autism: Parent views Journal of Autism and Developmental Disorders 22: 265–275
Dunn-Geier J., Ho H. H., Auersperg E., Coyle D. (2000). Effect of secretin on children with autism: A randomized controlled trial Developmental Medicine & Child Neurology 42: 796–802
Evangeliou A., Vlachonikolis I., Mihailidou H. (2003). Application of ketogenic diet in children with autistic behavior: Pilot study Journal of Child Neurology 18: 113–118
Field D., Garland M., Williams K. (2003). Correlates of specific childhood feeding problems Journal of Pediatric Child Health 39: 299–304
Finegold S. M., Molitoris D., Song Y., Liu C., Vaisanen M. L., Bolte E., McTeague M., Sandler R., Wexler H. (2002). Gastrointestinal microflora studies in late-onset autism Clinical Infectious Diseases 35: S6–S16
Fombonne E., Chakrabarti S. (2001). No evidence for a new variant of measles-mumps-rubella-induced autism Pediatrics 108(4): E58
Furlano R. L., Anthony A., Day R., Brown A., McGarvey L., Thomson M. A., Davies S. E., Berelowitz M., Frobes A., Wakefield A. J., Walker-Smith J. A., Murch S. H. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism Journal of Pediatrics 138: 366–372
Hendrickson B. A., Turner J. R. (2002). MMR vaccination, ileal lymphoid nodular hyperplasia, and pervasive developmental disorder Lancet 359: 2051–2052
Hoekstra J. H. (1998). Toddler diarrhoea: A more nutritional disorder than a disease Archives of Disease in Childhood 79: 2–5
Honomichl R. D., Goodlin-Jones B. L., Burnham M. M., Hansen R. L., Anders T. F. (2002). Secretin and sleep in children with autism Child Psychiatry and Human Development 33: 107–123
Horvath K., Medeiros L., Rabszlyn A. (2000a). High prevalence of gastrointestinal symptoms in autistic children with autistic spectrum disorder Journal of Pediatric Gastroenterology and Nutrition 31: S174
Horvath K., Papadimitriou J. C., Rabsztyn A., Drachenberg C., Tildon J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder Journal of Pediatrics 135: 559–563
Horvath K., Perman J. A. (2002a). Autism and gastrointestinal symptoms Current Gastroenterology Reports 4: 251–258
Horvath K., Perman J. A. (2002b). Autistic disorder and gastrointestinal disease Current Opinion in Pediatrics 14: 583–587
Horvath K., Stefanatos G., Sokolski K. N., Wachtel R., Nabors L., Tildon J. T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorders Journal of the American Association for Academic Minority Physicians 9: 9–15
Horvath K., Zielke R. H., Collins R. M., Rabsztyn A., Medeiros L. A., Perman J. (2000b). Secretin improves intestinal permeability in autistic children Journal of Pediatric Gastroenterology and Nutrition 31: S31
Jyonouchi H., Sun S., Itokazu N. (2002). Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder Neuropsychobiology 46: 76–84
Kaminska B., Czaja M., Kozielska E., Mazur E., Korzon M. (2002). Use of secretin in treatment of childhood autism Medical Science Monitor 8: RA22–26
Kawashima H., Mori T., Kashiwagi Y., Takekuma K., Hoshika A., Wakefield A. J. (2000). Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism Digestive Diseases and Sciences 45: 723–729
Kern J. K., Miller V. S., Evans P. A., Trivedi M. H. (2002). Efficacy of porcine secretin in children with autism and pervasive developmental disroder Journal of Autism and Developmental Disorders 32: 153–160
Knivsberg A., Reichelt K. L., Nodland N., Hoien T. (1995). Autistic syndrome and diet: A follow-up study Scandinavian Journal of Education and Research 39: 223–236
Knivsberg A. M., Reichelt K. L., Hoien T., Nodland M. (2002). A randomized, controlled study of dietary intervention in autistic syndromes Nutritional Neuroscience 5: 251–261
Kokkonen J., Karttunen T. J. (2002). Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: An indication of enhanced immune response? Journal of Pediatric Gastroenterology and Nutrition 34: 42–46
Kuddo T., Nelson K. B. (2003). How common are gastrointestinal disorders in children with autism? Current Opinion in Pediatrics 15: 339–343
Lightdale J. R., Hayer C., Duer A., Lind-White C., Jenkins S., Siegel B., Elliot G. R., Heyman M. B. (2001). Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: A single-blinded, open-label pilot study Pediatrics 108: E90
Lightdale J. R., Siegel B., Heyman M. B. (2001). Gastrointestinal symptoms in autistic children Clinical Perspectives on Gastroenterology 1: 56–58
Linday L. A. (1997). Oral famotidine: A potential treatment for children with autism Medical Hypotheses 48: 381–386
Linday L. A., Tsiouris J. A., Cohen I. L., Shindledecker R., DeCresce R. (2001). Famotidine treatment of children with autistic spectrum disorders: Pilot research using single subject research design Journal of Neural Transmission 108: 593–611
Loening-Baucke V. (1998). Constipation in children The New England Journal of Medicine 339: 1155–1156
Lucarelli S., Frediani T., Zingoni A. M., Ferruzzi F., Giardini O., Quintieri F., Barbato M., D’Eufemia P., Cardi E. (1995). Food allergy and infantile autism Panminerva Medica 37: 137–141
Malloy C. A., Manning-Courtney P., Swayne S., Bean J., Brown J. M., Murray D. S., Kinsman A. M., Brasington M., Ulrich C. D. (2002). Lack of benefit of intravenous synthetic human secretin in the treatment of autism Journal of Autism and Developmental Disorders 32: 545–551
McCarthy D. M., Coleman M. (1979). Response of intestinal mucosa to gluten challenge in autistic subjects Lancet 2: 877–878
McMillin D. L., Richards D. G., Mein E. A., Nelson C. D. (1999). The abdominal brain and the enteric nervous system Journal of Alternative and Complementary Medicine 5: 575–586
Melmed R. D., Schneider C. K., Fabes R. A., Phillips J., Reichelt K. (2000). Metabolic markers and gastrointestinal symptoms in children with autism and related disorders Journal of Pediatric Gastroenterology and Nutrition 3: S31–S32
Murch S. H., MacDonald T. T., Walker-Smith J. A., Levin M., Lionetti P., Klein N. J. (1993). Disruption of sulphated glycosaminoglycans in intestinal inflammation Lancet 341: 711–714
O’Banion D., Armstrong B., Cummings R. A., Strange J. (1978). Disruptive behavior: A dietary approach Journal of Autism and Childhood Schizophrenia 8: 325–337
Owley T., McMahon W., Cook E. H., Laulhere T., South M., Zellmer L. (2001). Multisite, double blind, placebo-controlled trial of porcine secretin in autism Journal of the American Academy of Child and Adolescent Psychiatry 40: 1293–1299
Patel N. C., Yeh J. Y., Shepherd M. D., Crismon M. L. (2002). Secretin treatment for autistic disorder: A critical analysis Pharmacotherapy 22: 905–914
Pavone L., Fiumara A., Bottaro G., Mazzone D., Coleman M. (1997). Autism and celiac disease: Failure to validate the hypothesis that a link might exist Biological Psychiatry 42: 72–75
Quigley E. M. (2000). Autism and the gastrointestinal tract American Journal of Gastroenterology 95: 2154–2156
Raiten D. J., Massaro T. (1986). Perspectives on the nutritional ecology of autistic children Journal of Autism and Developmental Disorders 16: 133–143
Reichelt K. L., Ekrein J., Scott H. (1990). Gluten, milk proteins and autism: Dietary intervention effects on behavior and peptide secretion Journal of Applied Nutrition 42: 1–11
Reichelt K. L., Knivsberg A. M., Lind G., Nodland M. (1991). Probable etiology and possible treatment of childhood autism Brain Dysfunction 4: 308–319
Roberts W., Weaver L., Brian J., Bryson S. (2001). Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo controlled trial Pediatrics 107: e71
Sandler A. D., Sutton K. A., DeWeese J., Girardi M. A., Sheppard V., Bodfish J. W. (1999). Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder The New England Journal of Medicine 341: 1801–1806
Sandler R. H., Finegold S. M., Bolte E. R., Buchanan C., Maxwell A. P., Vaisanen M. L., Nelson M. N., Wexler H. (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism Journal of Child Neurology 15: 429–435
Shearer T. R., Larson K., Neushwander J., Gedney B. (1982). Minerals in the hair and nutrient intake of autistic children Journal of Autism and Developmental Disorders 12: 25–34
Sponheim E., Oftedal G., Helverschou B. (2002). Multiple doses of secretin in the treatment of autism: A controlled study Acta Paediatrica 91: 540–545
Tanguay P. E. (2002). Commentary: The primacy of the scientific method Journal of the American Academy of Child and Adolescent Psychiatry 41: 1322–1323
Taylor B., Miller E., Lingam R. (2002). Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study British Medical Journal 324: 393–396
Torrente F., Ashwood P., Day R., Machado N., Furlano R. I., Anthony A., Davies S. E., Wakefield A. J., Thomson M. A., Walker-Smith J. A., Murch S. H. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism Molecular Psychiatry 7: 375–382
Uhlmann V., Martin C. M., Scheils O., Pilkington L., Silva I., Killalea A., Murch S. B., Walker-Smith J. A., Thomson M. A., Wakefield A. J., O’Leary J. J. (2002). Potential viral pathogenic mechanism for a new variant inflammatory bowel disease Journal of Clinical Pathology – Molecular Pathology 55: 84–90
Unis I. S., Munson J. A., Rogers S. J., Goldson E., Osterling J., Gabriels R., Abbott R. D., Dawson G. (2002). A randomized, double-blind, placebo controlled trial of porcine versus synthetic secretin for reducing symptoms of autism Journal of the American Academy of Child and Adolescent Psychiatry 41: 1315–1321
Wakefield A. J., Anthony A., Murch S. H., Thomson M. A., Montgomery S. M., Davies S., O’Leary J. J., Berelowitz M., Walker-Smith J. A. (2003). Enterocolitis in children with developmental disabilities The American Journal of Gastroenterology 95: 2285–2295
Wakefield A. J., Anthony A., Schepelmann S., Kawashima H., Sim R., Khan K., Murch S. H., Dhillon A. P., Montgomery S. M., Thomson M. A., Thomas J., Walker-Smith J. A. (1998a). Persistent measles virus (MV) infection and immunodeficiency in children with autism, ileo-colonic lymphonodular hyperplasia and non-specific colitis Gut 42: A86
Wakefield A. J., Murch S. H., Anthony A., Linnell J., Casson D. M., Malik M., Berelowitz M., Dhillon A. P., Thomson M. A., Harvey P., Valentine A., Davies S. E. (1998b). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351: 637–641
Wakefield A. J., Murch S. H., Anthony A., Linnell J., Thomas J., Berelowitz M., Dhillon A. P., Thomson M. A., Davies S. E., Walker-Smith J. A. (1998c). Autistic enteropathy: A new inflammatory bowel disease? Gut 42: A84–A85
Wakefield A. J., Puleston J. M., Montgomery S. M., Anthony A., O’Leary J. J., Murch S. H. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands Alimentary Pharmacology and Therapeutics 16: 663–674
Walker-Smith J. A., Andrews J. (1972). Alpha-antitrypsin, autism and celiac disease Lancet 2: 883–884
Acknowledgments
This work was supported in part by a Daniel X. Freedman Psychiatric Research Fellowship Award (Dr. Posey), a National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award (Dr. Posey), a Research Unit on Pediatric Psychopharmacology Grant (U10-MH66766-02) from the National Institute of Mental Health (NIMH) to Indiana University (Drs. McDougle, Stigler, and Posey), a Research Career Development Award (K23-MH068627-01) from NIMH (Dr. Posey), a National Institutes of Health Clinical Research Center Grant to Indiana University (M01-RR00750), and a Department of Housing and Urban Development (HUD) Grant No. B-01-SP-IN-0200 (Dr. McDougle).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erickson, C.A., Stigler, K.A., Corkins, M.R. et al. Gastrointestinal Factors in Autistic Disorder: A Critical Review. J Autism Dev Disord 35, 713–727 (2005). https://doi.org/10.1007/s10803-005-0019-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-005-0019-4